CVS sells $1.5 billion in tobacco a year, but CVS officials said selling cigarettes while promoting wellness doesn't make sense.
"Selling tobacco is very inconsistent with being in that business," said Helena Foulkes, CVS's president. "We really thought about this decision as it relates to the future as a health company ��it's good for customers and our company, in the long run."
Foulkes told USA TODAY that CVS sees its future as an alternative to the doctor's office, with 26,000 pharmacists and nurse practitioners counseling customers about how to control their high cholesterol, diabetes and high blood pressure.
"Any form of tobacco use makes those chronic conditions more difficult to deal with," she said. "This is good for business and the right thing to do."
Best Penny Companies To Watch For 2015: Conatus Pharmaceuticals Inc (CNAT)
Conatus Pharmaceuticals Inc., incorporated on July 13, 2005, is a biotechnology company focused on the development and commercialization of medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. The Company has designed a clinical program to demonstrate the therapeutic benefit of emricasan across the spectrum of fibrotic liver disease. The Company�� initial development strategy targets indications for emricasan with high unmet clinical need in orphan patient populations, such as patients with acute-on-chronic liver failure (ACLF), chronic liver failure (CLF), and patients who have developed liver fibrosis post-orthotopic liver transplant due to Hepatitis C virus infection (HCV-POLT).
The Company has completed two placebo-controlled Phase II trials in patients with liver disease showing reductions in ALT levels that occur rapidly, within as little as one day after initiation of therapy, and are maintained throughout the treatment period. In the Company�� 204-patient Phase 2b trial, it also measured cCK18, an important biomarker of apoptosis and disease severity. Emricasan has been generally well-tolerated in all of the clinical studies. As of July 23, 2013, the Company had not generated any revenue.
Advisors' Opinion:- [By Lauren Pollock]
Conatus Pharmaceuticals Inc.'s(CNAT) shares jumped 26% to $7.75 premarket after the biotechnology firm said its treatment for chronic liver disease has been granted a status that could mean quicker approval.
Best Healthcare Equipment Companies To Buy For 2014: Sutor Technology Group Ltd (SUTR)
Sutor Technology Group Limited, incorporated on May 1, 1997, manufacture fine finished steel products. The Company utilizes a range of processes and technological methodologies to converts steel manufactured by third parties into fine finished steel products. The Company's product offerings are focused on finished steel products, specifically hot-dip galvanized steel (HDG steel), and pre-painted galvanized steel, or PPGI. In addition, the Company produces acid pickled steel (AP steel), and cold-rolled steel. The Company's three operating segments are categorized according to the Company's three operating subsidiaries, which include Changshu Huaye, which manufactures and sells HDG steel and PPGI products; Jiangsu Cold-Rolled, which manufactures and sells HDG steel, AP steel and cold-rolled steel, and Ningbo Zhehua, which manufactures and sells welded steel pipe products.
The Company sells its products to customers who operate primarily in the solar energy, appliances, automobile, construction, infrastructure, medical equipment and water resource industries. The Company's primary export markets are Europe, the Middle East, Asia, and South America. The Company's manufacturing facilities, located in Changshu, China, have three HDG steel production lines, one PPGI production line, one AP steel production line and one cold-rolled steel line. The Company's products include HDG steel, PPGI, AP steel, cold-rolled steel and welded steel pipe products. The Company's HDG steel and PPGI products are primarily manufactured by Changshu Huaye and the Company's AP steel and cold-rolled steel products are primarily manufactured by Jiangsu Cold-Rolled.
HDG Steel
The Company manufactures corrosion-resistant and zinc-coated HDG steel in different dimensions and using different materials and specifications by its customers. HDG steel products are manufactured from steel substrate of cold-rolled or hot-rolled pickled coils by applying zinc to the surface of the material to enhance its! corrosion protection. HDG steel products are principally used in the electrical household appliances and construction markets. Sales of HDG steel products amounted to approximately 451,269 MT in fiscal year 2012, representing approximately 63.8% of the Company's total revenue. The Company's HDG steel products are manufactured by Changshu Huaye and Jiangsu Cold-Rolled. Changshu Huaye produces only HDG of cold-rolled steel.
PPGI Products
PPGI products are made to order based on customer specifications. The Company's PPGI products��specification generally ranges from 700mm to 1250mm in width and from 0.2mm to 1.2mm in thickness. The Company's PPGI products are used in solar energy, appliances and construction materials. The Company produces its PPGI by color-coating on HDG of cold-rolled steel and then coating them in various colors according to customer requirements. The Company's PPGI production line is equipped with the twice baking and coating technology, which together with indirect heating, enhances the color coated layers adhesion to the galvanized zinc layer.
AP Steel
Acid pickling is a process that removes scales and oxides from the steel surface by pickling, cold rolling and annealing. AP steel products are used as a raw material for cold-rolled steel strip, HDG steel, as well as components of automobile and manufacturing equipment. AP steel products come in several different dimensions and using different materials and different specifications.
Full-Hard, Cold-rolled Steel Products
Full-hard cold-rolled steel strips are treated in an annealing process and are used to produce HDG of cold-rolled steel. The Company produces full-hard cold-rolled steel strips through a reverse cold rolling mill.
Welded Steel Pipe Products
The Company's subsidiary Ningbo Zhehua has one advanced Joint Center of Excellence (JCOE) production line for large-diameter, double-side, submerged-arc welded steel pipes, t! hree US L! incoln production lines for spiral seam, double-side, submerged-arc welded steel pipes, and two REF production lines for roll-bending, double-side, submerged-arc welded steel pipes. Ningbo Zhehua is specialized in manufacturing large-diameter, double-side, submerged-arc welded steel pipes and spiral seam steel pipes. The finished products are used for oil and gas transmission, municipal water supply projects, sewage treatment projects, and piling.
The Company competes with ArcelorMittal and Posco Steel.
Advisors' Opinion:- [By James E. Brumley]
To tell the truth, I had almost forgotten about Sutor Technology Group Ltd. (NASDAQ:SUTR) after posting my "right stock, wrong time" speech back on the 9th. While I loved the way SUTR had broken past a horizontal ceiling at $1.83 after several weeks' worth of trying, the bullish move itself was a little overheated and looked like it was setting up a near-term pullback. Only after that dip would the stock be a healthy buy again.
- [By Monica Gerson]
Sutor Technology Group (NASDAQ: SUTR) is projected to report its Q4 earnings at $0.10 per share on revenue of $152.96 million.
Le Gaga Holdings (NASDAQ: GAGA) is estimated to report its Q4 earnings.
Best Healthcare Equipment Companies To Buy For 2014: Cullen/Frost Bankers Inc (CFR)
Cullen/Frost Bankers, Inc. (Cullen/Frost), incorporated in 1977, is a financial holding company and a bank holding company. The Company offers commercial and consumer banking services, as well as trust and investment management, mutual funds, Section 1031 property exchange services, investment banking, insurance, brokerage, leasing, asset-based lending, treasury management and item processing services. At December 31, 2011, Cullen/Frost had consolidated total assets of $20.3 billion. The Company operates in two segments: Banking and Frost Wealth Advisors. The Company serves a variety of industries including, among others, energy, manufacturing, services, construction, retail, telecommunications, healthcare, military and transportation. On January 1, 2012, the Company acquired Stone Partners, Inc., a Houston-based human resources consulting firm that specializes in compensation, benefits and outsourcing services. During the year ended December 31, 2011, the Company acquired an insurance agency in the San Antonio market area.
Cullen/Frost�� subsidiaries include The New Galveston Company, Cullen/Frost Capital Trust II (Trust II), The Frost National Bank (Frost Bank), Frost Insurance Agency, Inc., Frost Brokerage Services, Inc. (FBS), Frost Premium Finance Corporation, Frost Investment Advisors, LLC, Frost 1031 Exchange, LLC, Frost Securities, Inc. and Main Plaza Corporation. The Banking operating segment includes both commercial and consumer banking services, Frost Securities, Inc. and Frost Insurance Agency. Commercial banking services are provided to corporations and other business clients and include an array of lending and cash management products. Consumer banking services include direct lending and depository services. Frost Insurance Agency provides insurance brokerage services to individuals and businesses covering corporate and personal property and casualty products, as well as group health and life insurance products. Frost Securities, Inc. provides advisory and private equity s! ervices to middle market companies. The Frost Wealth Advisors operating segment includes fee-based services within private trust, retirement services, and financial management services, including personal wealth management and brokerage services. The parent company�� principal activities include the direct and indirect ownership of the Corporation�� banking and non-banking subsidiaries and the issuance of debt and equity.
The New Galveston Company
The New Galveston Company is a wholly owned second-tier financial holding company and bank holding company. The Company directly owns all of Cullen/Frost�� banking and non-banking subsidiaries with the exception of Cullen/Frost Capital Trust II.
Cullen/Frost Capital Trust II
Trust II is a business trust formed for the purpose of issuing trust preferred securities and lending the proceeds to Cullen/Frost. Trust II is a variable interest entity for which the Company is not the primary beneficiary.
The Frost National Bank
The Frost National Bank (Frost Bank) is primarily engaged in the business of commercial and consumer banking through approximately 115 financial centers across Texas in the Austin, Corpus Christi, Dallas, Fort Worth, Houston, Rio Grande Valley and San Antonio regions. At December 31, 2011, Frost Bank had consolidated total assets of $20.3 billion and total deposits of $16.8 billion. Frost Bank provides commercial banking services to corporations and other business clients. Loans are made for a variety of general corporate purposes, including financing for industrial and commercial properties and to a lesser extent, financing for interim construction related to industrial and commercial properties, financing for equipment, inventories and accounts receivable, and acquisition financing, as well as commercial leasing and treasury management services.
Frost Bank provides a range of consumer banking services, including checking accounts, savings progra! ms, autom! ated teller machines, overdraft facilities, installment and real estate loans, home equity loans and lines of credit, drive-in and night deposit services, safe deposit facilities, and brokerage services. Frost Bank provides international banking services to customers residing in or dealing with businesses located in Mexico. These services consist of accepting deposits, making loans, issuing letters of credit, handling foreign collections, transmitting funds, and to a limited extent, dealing in foreign exchange.
Frost Bank acts as correspondent for approximately 316 financial institutions, which are primarily banks in Texas. These banks maintain deposits with Frost Bank, which offers them a range of services, including check clearing, transfer of funds, fixed income security services, and securities custody and clearance services. Frost Bank provides a range of trust, investment, agency and custodial services for individual and corporate clients. These services include the administration of estates and personal trusts, as well as the management of investment accounts for individuals, employee benefit plans and charitable foundations. Frost Bank�� Capital Markets Division offers services, such as sales and trading, new issue underwriting, money market trading, and securities safekeeping and clearance.
Frost Insurance Agency, Inc.
Frost Insurance Agency, Inc. is a wholly owned subsidiary of Frost Bank. Frost Insurance Agency, Inc. provides insurance brokerage services to individuals and businesses covering corporate and personal property and casualty insurance products, as well as group health and life insurance products.
Frost Brokerage Services, Inc.
FBS is a wholly owned subsidiary of Frost Bank. FBS provides brokerage services and performs other transactions or operations related to the sale and purchase of securities of all types.
Frost Premium Finance Corporation
Frost Premium Finance Corporation is a who! lly owned! subsidiary of Frost Bank. Frost Premium Finance Corporation makes loans to qualified borrowers for the purpose of financing their purchase of property and casualty insurance.
Frost Investment Advisors, LLC
Frost Investment Advisors, LLC is a registered investment advisor entity and a wholly owned subsidiary of Frost Bank. Frost Investment Advisors, LLC provides investors access to various Frost-managed mutual funds.
Frost 1031 Exchange, LLC
Frost 1031 Exchange, LLC is a wholly owned subsidiary of Frost Bank. Frost 1031 Exchange, LLC assists customers in structuring the exchange of property such that the transactions result in a tax-deferred exchange in compliance with Section 1031 of the Internal Revenue Code.
Frost Securities, Inc.
Frost Securities, Inc. is a wholly owned subsidiary of The New Galveston Company. Frost Securities, Inc. provides advisory and private equity services to middle market companies in Texas.
Main Plaza Corporation
Main Plaza Corporation is a wholly owned non-banking subsidiary of The New Galveston Company. Main Plaza Corporation occasionally makes loans to qualified borrowers.
Advisors' Opinion:- [By Namitha Jagadeesh]
UniCredit SpA and Standard Chartered Plc climbed more than 2 percent each as a gauge of lenders advanced. Randgold Resources Ltd. and Polymetal International Plc jumped more than 8 percent as the price of gold rose. Cie. Financiere Richemont SA (CFR) and Swatch Group AG advanced more than 1 percent as a report showed Swiss watch exports increased last month.
- [By Sarah Jones]
Richemont (CFR) rallied 8.3 percent to 73.80 Swiss francs, the biggest gain since December 2008. The Swiss company said full- year net income climbed about 30 percent as the dollar�� strength against the euro boosted sales growth. Analysts had expected a 25 percent gain in profit, according to the average of 17 estimates compiled by Bloomberg.
- [By Sofia Horta e Costa]
Sanofi fell 2.6 percent after withdrawing a U.S. application for a diabetes drug. Cie. Financiere Richemont (CFR) SA dropped 2.3 percent as revenue missed analysts��estimates. Vivendi SA advanced 2.7 percent after saying it will begin a formal study to separate its French phone unit from its media businesses. Home Retail Group Plc (HOME) surged 5.4 percent to a two-year high as sales exceeded projections.
Best Healthcare Equipment Companies To Buy For 2014: Sucampo Pharmaceuticals Inc (SCMP)
Sucampo Pharmaceuticals, Inc., incorporated on December 9, 2008, is a global biopharmaceutical company focused on research, discovery, development and commercialization of drugs based on ion channel activators known as prostones. The Company�� prostone-based compounds target the ClC-2 and big potassium (BK), ion channels. It is focused on developing prostones to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, and is also considering other therapeutic applications of its drug technology. The Company�� products include AMITIZA (lubiprostone) and RESCULA (unoprostone isopropyl).
AMITIZA
The Company�� AMITIZA is being marketed in the United States for three gastrointestinal indications under a license agreement, or the Takeda Agreement, with Takeda Pharmaceutical Company Limited, or Takeda. The three gastrointestinal indications include chronic idiopathic constipation (CIC), in adults, irritable bowel syndrome with constipation (IBS-C), in adult women, and opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. AMITIZA for OIC received approval from the United States Food and Drug Administration (FDA), in April 2013. In Japan, AMITIZA is marketed under a license, commercialization and supply agreement, or the Abbott Agreement, with Abbott Japan Co. Ltd. (Abbott), for the gastrointestinal indication of chronic constipation (CC), excluding constipation caused by organic diseases. In Switzerland, the Company is marketing AMITIZA.
RESCULA
The Company holds license agreements for RESCULA in the United States and Canada and the rest of the world, with the exception of Japan, Korea, Taiwan and the People�� Republic of China. The Company is commercializing RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% for the lowering of intraocular pressure (IOP), in patients with open-angle glaucoma or ocular hypertension in the United States. RESCULA may be used as an agent or concomit! antly with other topical ophthalmic drug products to lower intraocular pressure. RESCULA is a BK channel activator and has a different mechanism of action than other IOP lowering agents on the market.
Advisors' Opinion:- [By James Brumley]
Still, for the nimble who know when to get out, OREX is one of the few cheap stocks worth a closer look.
Sucampo Pharmaceuticals (SCMP)Finally, though the price of $7.60 clearly qualifies it as one pf the cheapest of the cheap stocks out there in the pharmaceutical world, that’s not the reason Sucampo Pharmaceuticals (SCMP) may be worth a look here. It’s the 30% slide we’ve seen SCMP stock suffer since peaking in mid-January. It’s not a pullback that’s bound to go unchallenged by the bulls.
- [By Roberto Pedone]
Another under-$10 stock that's starting to trend within range of triggering a major breakout trade is Sucampo Pharmaceuticals (SCMP), which is engaged in the discovery, development and commercialization of proprietary drugs based on prostones, and other novel drug technologies. This stock is off to a decent start in 2013, with shares up by 26%.
If you take a look at the chart for Sucampo Pharmaceuticals, you'll notice that this stock has been downtrending badly for the last four months, with shares dumping hard from its high of $10.48 to its recent low of $5.40 a share. During that downtrend, shares of SCMP have been consistently making lower highs and lower lows, which is bearish technical price action. That said, the downside volatility for SCMP looks to be over in the short-term since the stock has started to reverse its downtrend and enter an uptrend. That reverse is quickly pushing shares of SCMP within range of triggering a major breakout trade above a key downtrend line.
Traders should now look for long-biased trades in SCMP if it manages to break out above some near-term overhead resistance levels at $6.33 to $6.66 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 115,383 shares. If that breakout triggers soon, then SCMP will set up to re-test or possibly take out its next major overhead resistance levels at $7.09 to $7.67 a share. Any high-volume move above those levels will then give SCMP a chance to tag $8 to $9 a share.
Traders can look to buy SCMP off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $5.58 to $5.40 a share. One can also buy SCMP off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Best Healthcare Equipment Companies To Buy For 2014: Smart Ventures Inc (SMVR)
Smart Ventures, Inc., incorporated on November 22, 2006, is an exploration-stage company. The Company focuses on exploring, acquiring, developing and producing mineral reserves. The Company had purchased certain mineral claims located in the Laurentides Region near Mont Laurier, Quebec. In June 2011, the Company acquired Metal Assets S.A. In February 2014, Smart Ventures Inc announced the closing of its acquisition of The Sanday Corporation oil and gas drilling Services Company.
As of December 31, 2009, the Company had not generated any revenues. The Company focuses on establishing and exploiting deposits of both base and precious metals.
Advisors' Opinion:- [By Peter Graham]
Small cap marijuana stocks Smart Ventures Inc (OTCMKTS: SMVR) and Vitamin Blue Inc (OTCMKTS: VTMB) jumped 40.28% and 38.6%, respectively, while hemp stock Astika Holdings Inc (OTCBB: ASKH) fell 13.75% on Friday. Moreover, only one of these small cap stocks seems to have been the subject of a few paid promotions or investor relations types of activities. So will all three of these marijuana or hemp stocks keep producing highs or lows for investors and traders alike? Here is a quick reality check:
Smart Ventures Inc (OTCMKTS: SMVR) Plans to Enter the Marijuana Edibles BusinessSmall cap Smart Ventures Inc is an independent energy company engaged in engineering extended reach drilling services, acquisition, development, production, and exploration of oil, gas and minerals internationally. On Friday, Smart Ventures Inc rose 40.28% to $0.07 for a market cap of $2.31 million plus SMVR is up 600% over the past year and down 93.3% in intermittent trading since December 2009 according to Google Finance.
Best Healthcare Equipment Companies To Buy For 2014: INTL FCStone Inc.(INTL)
INTL FCStone Inc., together with its subsidiaries, provides foreign exchange and treasury, securities execution, physical commodities trading and execution, and structured over-the-counter commodity services worldwide. It offers commodity and risk management services; treasury, global payment, and foreign exchange services; and wholesale market making services in select foreign securities, as well as involved in the origination, structuring, and placement of an array of emerging market debt instruments in the international and domestic capital markets, and trades in various international debt instruments. The company also provides clearing and execution services related to exchange-traded futures and options for the institutional and professional trader market segments; asset management, and commodity financing and facilitation services; and investment banking advisory services. Its customers comprise the producers, consumers, recyclers, and investors in precious metals an d certain base metals; financial institutions, multi-national corporations, and governmental and charitable organizations; and broker-dealers, regional broker-dealers, commercial banks, institutional investors, and investment banks. The company was formerly known as International Assets Holding Corporation and changed its name to INTL FCStone Inc. in March 2011. INTL FCStone Inc. was founded in 1924 and is headquartered in New York, New York.
Advisors' Opinion:- [By RichardCox]
Most of the evidence supporting positions in SPY over QQQ can be seen in the earnings performance so far this season. In the S&P as a whole, roughly 3/4 of the reporting companies have posted results that are better than analyst estimates. When looking at revenues in isolation, slightly more than half of those companies have passed market projections. But these numbers would be much improved without the major earnings misses that have been seen in the large-cap tech space. Examples seen so far include Intel Corp.(INTL), Advanced Micro Devices (AMD), and, more recently, Google(GOOG), and Microsoft (MSFT).
No comments:
Post a Comment